Montelukast Prescribing at PARKVIEW SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
917
Total Quantity
19.0K
NHS Cost
£935
vs National Avg
+33.9%
PARKVIEW SURGERY prescribed 917 items of Montelukast over the last 12 months at a cost of £935 to the NHS. This is 33.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
75
Jun 2026
80
Jun 2026
88
Jun 2026
79
Jun 2026
80
Jun 2026
75
Jun 2026
70
Jun 2026
70
Jun 2026
84
Jun 2026
75
Jun 2026
68
Jun 2026
73
Prescribing Details
| Total Items | 917 |
|---|---|
| Total Quantity | 19,012 |
| Total NHS Cost | £935 |
| Presentations | 3 different forms |
| vs National Average | +33.9% |
Montelukast Prescribing Comparison
| This practice | 917 items |
|---|---|
| National average per practice | 685 items |
| Difference | +33.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.